New Biotech Offering Targets $426B Rare Disease Market

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Nio, Rivian, Moderna, Meta And Bitmine Immersion: Why These 5 Stocks Are On Investors' Radars Today

Shivdeep Dhaliwal
September 16, 2025

On Tuesday, U.S. markets slipped, with the Dow Jones Industrial Average falling about 0.3% to 45,757.90, the S&P 500 retreating 0.1% to 6,606.76, and the Nasdaq edging down 0.07% to 22,333.96.

These are the top stocks that gained the attention of retail traders and investors throughout the day.

Nio Inc. (NYSE:NIO)

Nio’s stock surged by 8.17%, closing at $7.02. The stock hit an intraday high of $7.09 and a low of $6.48, with a 52-week range of $7.71 to $3.02. The rise follows UBS’s upgrade of Nio from Neutral to Buy, with a price target increase from $6.20 to $8.50. Additionally, Nio’s shipment of a new model to dealers contributed to the positive momentum.

Rivian Automotive, Inc. (NASDAQ:RIVN)

Rivian’s shares climbed 5.29%, ending the day at $14.32. The stock reached a high of $14.65 and a low of $13.73, within a 52-week range of $17.15 to $9.50. The increase comes after Rivian announced its expansion in the U.S. with a new facility in Georgia. The groundbreaking ceremony marked a significant step in their electric vehicle production.

Moderna Inc. (NASDAQ:MRNA)

Moderna’s stock rose by 4.02%, closing at $24.84. The day’s high was $25.63, with a low of $23.91, and the 52-week range was $75.37 to $23.15. This uptick followed the release of preliminary data showing an eight-fold increase in antibodies with their updated Spikevax formula targeting the LP.8.1 variant of SARS-CoV-2.

Meta Platforms Inc. (NASDAQ:META)

Meta’s shares increased by 1.87%, closing at $779. The stock’s intraday high was $781.36, with a low of $765.10, and a 52-week range of $796.25 to $479.80. The rise came after a leak revealed Meta’s next-generation smart glasses, which the analyst Ross Gerber called a “game changer.”

BitMine Immersion Technologies Inc. (NYSE:BMNR)

BitMine’s stock rose by 5.31%, closing at $55.93. The stock’s high was $57.01, with a low of $50.90, and a 52-week range of $161 to $3.20. The increase follows BitMine’s report of holding over 2.15 million Ethereum (CRYPTO: ETH) tokens, making it the world’s largest Ethereum treasury company.

Benzinga’s Edge Stock Rankings show that Rivian has a Momentum in the 60th percentile and Growth in the 24th percentile. Here is how it compares against Tesla and Nio.

Prepare for the day’s trading with top premarket movers and news by Benzinga.

Photo Courtesy: Summit Art Creations on Shutterstock.com

Read Next:

  • Cathie Wood’s Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI

This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal

Continue Reading...

Popular

MP Materials Tops List For Rare Earth Exposure, Says Analyst

Rare earth stocks are gaining attention as demand for magnets in EVs, robotics, and advanced air mobility is set to double by 2035.

Tesla Set To Hit $3 Trillion in 2026—Dan Ives

Tesla bull and Wedbush tech analyst Dan Ives sees Tesla reaching a $1 trillion valuation before the end of 2026. 

Crypto Meets Wall Street - Are You Ready? - Ad

The Hedge Fund Summit is bringing top minds from crypto and traditional finance together. Discover new strategies, insights, and connections that could shape your portfolio's future.

Web of business interests shows that Kimmel's future rests on far more than his jokes

NEW YORK (AP) — The decision about whether to keep on his late-night ABC show depends on far more than his jokes. The choice is complicated by a web of business and regulatory considerations involving ABC’s parent company, other media companies and the Trump administration.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Cathie Wood Loads Up On Bullish Inc, Pony AI And Robinhood — Dumps Kratos Defense Amid Taiwan Drone Buzz

On Sept 17, 2025, Cathie Wood-led Ark Invest executed significant trades involving Bullish, Kratos Defense, Pony AI, and Robinhood. These reflect Ark's focus on emerging tech and defense sectors.

Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI

On Tuesday, Cathie Wood-led Ark Invest executed significant trades, including buying shares of Advanced Micro Devices Inc. (NASDAQ:AMD) and Bullish Inc. (NYSE:BLSH), while selling shares o

Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad

If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."

New York City's Wealthiest Neighborhoods Witness 60% Rent Surge Since Pandemic

House rental rates in some of the wealthiest neighborhoods of New York City have surged by over 60% since the COVID-19 pandemic began, putting even high-income earners in a tight spot.

Lockheed Martin Counters Boeing's F-47 Victory With Cost-Effective F-35 Upgrade Using Sixth-Gen Technology

Lockheed Martin is countering Boeing's F-47 win with a cost-effective F-35 upgrade that integrates sixth-generation tech, aiming to offer 80% of the F-47's capabilities at half the price.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

BlackRock Turns Popular Mutual Funds Into Global Equity ETFs

BlackRock turns two top mutual funds into active ETFs, giving investors global equity exposure and strategies to manage volatility.

It's 'do or die' for electric vehicle maker Rivian as it breaks ground on a $5 billion plant

ATLANTA (AP) — It seems like a terrible time to build an electric vehicle plant in the United States, but Rivian Automotive leaders say they're confident as the company starts on a $5 billion facility in Georgia.

Nvidia Is About to Shock the World: October 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

Big Tech's energy-hungry data centers could be bumped off grids during power emergencies

HARRISBURG, Pa. (AP) — With the explosive growth of Big Tech's data centers threatening to overload U.S. electricity grids, policymakers are taking a hard look at a tough-love solution: bumping the energy-hungry data centers off grids during power emergencies.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

US jobless aid applications retreat to 231,000 after surging to nearly 4-year high a week earlier

The number of Americans applying for jobless aid last week retreated significantly after surging to a nearly four-year high a week earlier.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Charlie Kirk Raised $85 Million Last Year — Widow Vows to Continue His Work

The assassination of Turning Point USA founder Charlie Kirk at a Utah Valley University event on September 10 has cast a shadow of uncertainty over the future of his political and business ventures.

Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact

EMA approved Rybelsus' label update after the SOUL trial showed it cuts heart attack, stroke, and death by 14% in high-risk type 2 diabetes patients.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Warsaw turns to Ukraine for drone warfare expertise after Russian drones enter Polish airspace

KYIV, Ukraine (AP) — Poland’s defense chief traveled to Kyiv on Thursday in search of Ukrainian help in developing his country's drone warfare capabilities, just over a week after and exposed to drone warfare.

Nio Sends New ES8 SUVs To Dealers Ahead Of Launch

Nio Inc. (NYSE: NIO) shares rose 7.09% as UBS upgraded the stock and shipments of new model began. Price forecast also raised to $8.5.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

FDA takes aim at Hims and other telehealth services in drug advertising blitz

WASHINGTON (AP) — For the first time, federal health officials are taking aim at promoting unofficial versions of prescription drugs — including popular weight loss medications — as part of the on pharmaceutical advertising.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Utah Governor After Kirk Killing: 'Social Media Is A Cancer On Our Society Right Now'

Utah Gov. Spencer Cox urged unity after Charlie Kirk's killing, warning that "social media is a cancer on our society right now."

Crypto Meets Wall Street - Are You Ready? - Ad

The Hedge Fund Summit is bringing top minds from crypto and traditional finance together. Discover new strategies, insights, and connections that could shape your portfolio's future.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

SciSparc Stock Shoots Up Over 89% After Hours: What's Going On?

SciSparc's stock surged 89.13% to $3.48 after-hours on news of a court-granted stay in its merger with AutoMax, though the stock remains down 71.87% over the past year.

Long-wrought WTO agreement aimed at reducing overfishing takes effect

GENEVA (AP) — A World Trade Organization agreement aimed at reducing took effect Monday, requiring countries to reduce subsidies doled out to fishing fleets and aiming to ensure sustainability of wildlife in the world's seas and oceans.

Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad

If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."

Labor Dispute Eases As UAW, GE Aerospace Agree On Tentative Pact

UAW members at GE Aerospace plants in Ohio and Kentucky reached a tentative deal, with a ratification vote set for Sept. 19.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright smartmoneytrading.net
Privacy Policy | Terms of Service